1-4 of 4
Francis J. Giles, MD MB, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Treatment Cessation on Overall Disease Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Attempting Treatment-Free Remission (TFR): Findings from Enestfreedom and Enestop

Giuseppe Saglio, MD PhD, Timothy P. Hughes, MD, Andreas Hochhaus, MD, Dong-Wook Kim, MD PhD, Francis J. Giles, MD MB, FRCPath, Jerald P. Radich, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Prashanth Gopalakrishna, MD, Weiping Deng, Rafik Fellague-Chebra, MD, Sandip Acharya, MSc, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1598.
https://doi.org/10.1182/blood.V130.Suppl_1.1598.1598
Published: 2017
Journal Articles

Molecular Recurrence-Free Survival (MRecFS) Following Imatinib Vs. Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Matched Analysis of Patients in EURO-SKI and Enestfreedom

Markus Pfirrmann, Francois-Xavier Mahon, MD PhD, Joelle Guilhot, PhD, Johan Richter, MD PhD, Francis J. Giles, MD MB, FRCPath, Andreas Hochhaus, MD, Jerald P. Radich, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Giuseppe Saglio, MD PhD, Weiping Deng, Darshan Dalal, MPH, MD PhD, Susanne Saussele, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1601.
https://doi.org/10.1182/blood.V130.Suppl_1.1601.1601
Published: 2017
Journal Articles

Treatment-Free Remission (TFR) Among Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Not Initially Eligible for Treatment Discontinuation Due to Unstable Deep Molecular Response (DMR): Enestfreedom and Enestop

Timothy P. Hughes, MD, Andreas Hochhaus, MD, Dong-Wook Kim, MD PhD, Francois-Xavier Mahon, MD PhD, Francis J. Giles, MD MB, FRCPath, Jerald P. Radich, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Prashanth Gopalakrishna, MD, Weiping Deng, Rafik Fellague-Chebra, MD, Sandip Acharya, MSc, Giuseppe Saglio, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2878.
https://doi.org/10.1182/blood.V130.Suppl_1.2878.2878
Published: 2017
Journal Articles

A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase a, in Myelofibrosis

Naseema Gangat, MBBS, Ronan T. Swords, MD PhD FRCPI, FRCPath, Brady Lee Stein, MDMHS, Christian Marinaccio, Justin M Watts, MD, Olga Frankfurt, MD, Jessica K. Altman, MD, Aref Al-Kali, MD, Darci Zblewski, CNP, Sandeep Gurbuxani, Jeremy Q. Wen, MD PhD, Roberto Tapia, BS, Stephanie Barath, Amy Graf, Amy Handlogten, Yvonne Trang Dinh, BS, Kristen Englund, Shradha Patel, Orlando Bodes, Jillian Ogden, Francis J. Giles, MD MB, FRCPath, Ayalew Tefferi, MD, John D. Crispino, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1631.
https://doi.org/10.1182/blood.V130.Suppl_1.1631.1631
Published: 2017